The La Crosse Virus G1 Activators is a class of compounds that would directly or indirectly influence the activity of the G1 glycoprotein of the La Crosse Virus (LACV). LACV is an arbovirus, specifically a member of the Bunyaviridae family, known to cause severe encephalitis in humans. The G1 glycoprotein is a crucial component of the virus's structure, playing a significant role in viral entry into the host cell. The G1 glycoprotein, along with G2, forms spikes on the surface of the virion, which interact with host cell receptors to facilitate entry. As of now, specific activators or inhibitors of the G1 protein are not well studied or identified.
Compounds in the La Crosse Virus G1 Activators class would exert their influence through a range of mechanisms, potentially impacting the stages of viral replication where the G1 protein plays a role. For instance, some compounds might alter the host cell environment to favor the function of the G1 protein, such as modifying the pH of endosomes, which is a critical factor during the viral entry process. Other compounds could influence the synthesis or maturation of the G1 protein in the host cell, by affecting the broader cellular processes of protein synthesis and processing. Yet another group of compounds might enhance the interactions between the G1 protein and the host cell receptors, facilitating the viral entry process.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Induces production of interferons, potentially inhibiting viral replication and indirectly affecting G1 protein function | ||||||
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
Blocks ion channels formed by viral proteins, potentially affecting G1 protein function or assembly | ||||||
Rimantadine Hydrochloride | 1501-84-4 | sc-205842 sc-205842A | 25 mg 50 mg | $47.00 $104.00 | ||
Similar to Amantadine, it could influence G1 protein function or formation by inhibiting viral ion channels | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
Has broad antiviral properties, potentially inhibiting viral processes involving the G1 protein | ||||||
Myricetin | 529-44-2 | sc-203147 sc-203147A sc-203147B sc-203147C sc-203147D | 25 mg 100 mg 1 g 25 g 100 g | $97.00 $188.00 $260.00 $510.00 $1022.00 | 3 | |
Has antiviral activities, possibly inhibiting viral proteases or polymerases that could affect the G1 protein | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Has broad-spectrum antiviral activity, though its mechanism isn't fully understood, it could potentially influence G1 protein function or assembly | ||||||
Nitazoxanide | 55981-09-4 | sc-212397 | 10 mg | $124.00 | 1 | |
Has antiviral activity possibly due to interference with protein maturation in the endoplasmic reticulum, potentially affecting the G1 protein | ||||||
Baloxavir marboxil | 1985606-14-1 | sc-507295 | 100 mg | $132.00 | ||
Inhibits cap-dependent endonuclease, which is necessary for viral mRNA synthesis, potentially affecting the synthesis of G1 protein | ||||||